|
Market Closed -
Nasdaq
23:00:00 06/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.140 USD | +0.71% |
|
-7.51% | +79.40% |
| Market Cap | 107M 95.04M 89.02M 80.62M 152M 10.31B 153M 1.07B 415M 5.26B 402M 393M 16.93B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 106M 93.91M 87.96M 79.66M 150M 10.19B 151M 1.06B 410M 5.2B 397M 388M 16.73B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | +0.71% | ||
| 1 week | -7.51% | ||
| Current month | -8.81% | ||
| 1 month | +5.15% | ||
| 3 months | +12.09% | ||
| 6 months | +125.24% | ||
| Current year | +79.40% |
| 1 week | 6.84 |  | 8.14 |
| 1 month | 6.24 | | 8.35 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
Gordon Bernard
BRD | Director/Board Member | 74 | 10/09/2010 |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/18/26 A | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 3/18/26 A | Free | Director | 5,800 | 0.0388% | ||
| 3/18/26 A | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | -7.51% | +128.12% | +294.48% | 106M | |
| +1.26% | -2.30% | +37.82% | +113.76% | 1,019B | |
| +0.73% | -6.31% | +35.06% | +62.14% | 610B | |
| +0.35% | +0.15% | +14.01% | +80.87% | 470B | |
| +1.72% | -4.54% | +59.14% | +37.01% | 344B | |
| +0.26% | -1.58% | +21.97% | +41.79% | 336B | |
| +0.60% | -3.48% | +11.37% | +34.33% | 266B | |
| +1.65% | -4.27% | -5.47% | +9.69% | 241B | |
| -0.09% | -3.71% | +35.15% | +51.88% | 218B | |
| -0.28% | -5.24% | +27.99% | +93.08% | 179B | |
| Average | +0.44% | -4.08% | +36.52% | +81.90% | 368.29B | |
| Weighted average by Cap. | +0.32% | -3.51% | +29.49% | +70.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.64M 31.51M 28.54M 53.81M 3.65B 54.25M 378M 147M 1.86B 142M 139M 5.99B | 44.52M 39.55M 37.05M 33.55M 63.27M 4.29B 63.79M 445M 173M 2.19B 167M 164M 7.04B |
| Net income | -6.48M -5.76M -5.39M -4.88M -9.21M -624M -9.28M -64.76M -25.13M -319M -24.32M -23.8M -1.03B | -2.84M -2.52M -2.36M -2.14M -4.03M -273M -4.06M -28.34M -11M -139M -10.65M -10.42M -449M |
| Net Debt | 2.61M 2.32M 2.17M 1.97M 3.71M 251M 3.74M 26.07M 10.12M 128M 9.79M 9.58M 413M | -1.26M -1.12M -1.05M -953K -1.8M -122M -1.81M -12.63M -4.9M -62.17M -4.75M -4.64M -200M |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | $7.140 | +0.71% | 22,580 |
| 05/10/26 | $7.090 | -4.06% | 57,057 |
| 02/10/26 | $7.390 | -1.60% | 22,629 |
| 01/10/26 | $7.510 | -4.09% | 73,339 |
| 30/09/26 | $7.830 | +2.35% | 9,962 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
